Developing new drugs that remain potent against emerging variants of COVID-19 is essential to stopping the spread of the highly contagious disease and protecting human health. After more than two ...
Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback